Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | MMP9 | P14780 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | NAAA | Q02083 | 1/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.39 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.39 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.39 |
| ▸ | MGLL | Q99685 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20133100 | 1.00 | L3MBTL1 (0.49) | L3MBTL1TDP1TSHRALDH1A1KDM4E | |
| SCHEMBL2568738 | 0.97 | L3MBTL1 (0.49) | L3MBTL1TDP1TSHRALDH1A1KDM4E | |
| SCHEMBL2077604 | 0.97 | L3MBTL1 (0.51) | L3MBTL1TDP1TSHRALDH1A1KDM4E | |
| SCHEMBL27032046 | 0.95 | ALDH1A1 (0.48) | L3MBTL1TDP1TSHRALDH1A1KDM4E | |
| SCHEMBL29198550 | 0.95 | L3MBTL1 (0.47) | L3MBTL1TDP1TSHRALDH1A1KDM4E | |
| SCHEMBL2078239 | 0.95 | ALDH1A1 (0.52) | L3MBTL1TDP1TSHRALDH1A1KDM4E | |
| SCHEMBL20294565 | 0.94 | ALDH1A1 (0.45) | L3MBTL1TDP1TSHRALDH1A1KDM4E | |
| SCHEMBL27032384 | 0.92 | TSHR (0.44) | L3MBTL1TDP1TSHRALDH1A1KDM4E | |
| SCHEMBL24773083 | 0.92 | TSHR (0.44) | L3MBTL1TDP1TSHRALDH1A1KDM4E | |
| SCHEMBL2076982 | 0.92 | ALDH1A1 (0.47) | L3MBTL1TDP1TSHRALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240174637-A1 | DEGRADERS OF GRK2 AND USES THEREOF | PIIZZI GRAZIA (US) | 2024-05-30 | — | — | US | disclosed |
| WO-2022159688-A9 | DEGRADERS OF GRK2 AND USES THEREOF | SONATA THERAPEUTICS, INC. (US) | 2023-09-21 | — | — | WO | disclosed |
| WO-2022159688-A1 | DEGRADERS OF GRK2 AND USES THEREOF | CYGNAL THERAPEUTICS, INC. (US) | 2022-07-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240174637-A1 | DEGRADERS OF GRK2 AND USES THEREOF | GRK2, GRK3, GRK1 | L3MBTL1 2436/4885TDP1 3394/4885TSHR 1412/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.